Whole blood rotation thrombelastometry in subjects undergoing vitamin K antagonist treatment: hypo- or hypercoagulable profiles?

Thrombosis Research

Volumn 122, Issue 4, 2008, Pages 568-569

  Spiezia, L ^a   Bertini, D ^a   Salmaso, L ^b   Simioni, P ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K;

BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD EXAMINATION; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; HEART ATRIUM FIBRILLATION; HUMAN; LETTER; LYSIS; PRIORITY JOURNAL; THROMBOELASTOGRAPHY; VENOUS THROMBOEMBOLISM; WHOLE BLOOD ROTATION THROMBELASTOMETRY;

AGED; AREA UNDER CURVE; BLOOD COAGULATION; BLOOD COAGULATION TESTS; CHEMISTRY, CLINICAL; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; THROMBELASTOGRAPHY; THROMBOSIS; VITAMIN K;

EID: 48049093708     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.04.006     Document Type: Letter

References (8)

1. Sørensen B., and Ingerslev J. Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa. J Thromb Haemost 2 (2004) 102-110
2. Johansen R.F., Sørensen B., and Ingerslev J. Acquired haemophilia: dynamic whole blood coagulation utilized to guide haemostatic therapy. Haemophilia 12 (2006) 190-197
3. Hvitfeldt Poulsen L., Christiansen K., Sørensen B., and Ingerslev J. Whole blood thrombelastographic profiles using minimal tissue factor activation can display hypercoagulation in thrombosis-prone patients. Scand J Clin Lab Invest 66 (2006) 329-336
4. O'Donnell, Riddell A., Owens D., Handa A., Pasi J., Hamilton G., and Perry D.J. Role of the Thrombelastograph as an adjunctive test in thrombophilia screening. Blood Coagul Fibrinolysis 15 (2004) 207-211
5. Sørensen B., Johansen P., Christiansen K., Woelke M., and Ingerslev J. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 1 (2003) 551-558
6. Sørensen B., Johansen P., Nielsen G.L., Sørensen J.C., and Ingerslev J. Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. Blood Coagul Fibrinollysis 14 (2003) 469-477
7. Hepner D.L., Concepcion M., and Bhavani-Shankar K. Coagulation status using thromboelastography in patients receiving warfarin prophylaxis and epidural analgesia. J Clin Anesth 14 (2002) 405-410
8. Traverso C., Arcelus J.I., and Caprini J.A. Role of thromboelastography in evaluating other anticoagulant agents: warfarin and heparin-dihydroergotamine. Semin Thromb Hemost 21 Suppl 4 (1995) 59-62